Experts InSight

In today's episode, host Dr. Jay Sridhar is joined by Dr. Bobeck Modjtahedi to discuss the American Academy of Ophthalmology's new guidelines on autoimmune retinopathy (AIR), recently published in Ophthalmology Retina. A member of the Academy's task force on AIR and lead author, Dr. Modjtahedi discusses a new diagnostic framework for categorizing AIR as probable, possible, or unlikely based on specific clinical criteria. The guidelines address the challenges in diagnosing this rare condition that mimics inherited retinal diseases, and outline a standardized approach to classification for both clinical practice and research.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Davinder Grover and Ronald Fellman join host Dr. Andrew Pouw to discuss their latest innovative surgical advancement: interventional valve-enhancing trabeculotomy (iVEnT), an angle-based minimally invasive glaucoma surgery (MIGS) procedure. Compared with a traditional goniotomy, this alternative approach may be less invasive, sparing tissue and offering faster visual recovery for glaucoma patients.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Michael Puente joins host Dr. Ben Young to share his experience founding the first eye clinic specifically for adult and pediatric patients with intellectual developmental delay. Dr. Puente provides practical tips for all ophthalmologists to improve their care for this vulnerable population.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Louise Mawn and Jonathan Siktberg sit down with host Dr. Amanda Redfern to share their work on a groundbreaking paradigm shift in the treatment of periorbital necrotizing fasciitis with dilute hypochlorous acid.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. M. Ali Khan and Ajay Kuriyan join host Dr. Jay Sridhar to discuss updates in the retina space, including the FDA approval of photobiomodulation for dry age-related macular degeneration (AMD), OCT and OCTA reimbursement changes, and surgical technology advances.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Pediatric ophthalmologists Drs. Michelle Cabrera and Alejandra de Alba join host Dr. Ben Young to discuss the pros and cons of using botulinum toxin (Botox) for treating patients with strabismus, and whether every pediatric ophthalmologist—or even general ophthalmologist—should have this technique in their toolbox.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Medicare Advantage (MA) plans (also known as "Part C") are rapidly increasing in use, and beneficiaries' co-pay and claims denials are becoming more frequent. In today's episode, host Dr. Andrew Pouw talks with Academy billing and advocacy experts Joy Woodke and Brandy Keys to learn more about MA plans and their impact on patients and how ophthalmologists deliver care.

To review the requirements put forth by your Medicare Administrative Contractor, visit the Academy's page on local coverage determination policies.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Host Dr. Amanda Redfern welcomes oculoplastic surgeons Drs. Davin Ashraf and Natalie Hoesly to discuss their approaches to postoperative pain management, with the help of a pain and addiction medicine specialist, Dr. Pat Liu.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Leading glaucoma experts Drs. Jamie Brandt and Pradeep Ramulu join host Dr. Andrew Pouw to talk about the burden of overdiagnosis and overtreatment of mild glaucoma, and mitigation strategies both in the clinic and at the policy desk.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.